Colonic methanogenesis in vivo and in vitro and fecal pH after resection of colorectal cancer and in healthy intact colon
- 18 October 2011
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 27 (2) , 171-178
Abstract
Purpose We compared colonic methanogenesis in vivo and in vitro as well as fecal pH in healthy subjects and in patients with resected colorectal cancer thus without the possible confounding effects of the tumor. Methods A total of 144 subjects, 96 with resected colorectal cancer (of whom, 48 were with metastatic disease), 48 healthy subjects with intact colon, were analyzed for breath methane, fecal methanogenesis in vitro and fecal pH. In addition, the association between methanogenesis and pH with cancer site, operation technique and abdominal discomfort was investigated. Results In vivo and in vitro methane measurements were in agreement. The percentage of breath methane excretors and fecal pH did not significantly differ in participants resected for colorectal cancer, either with (46%, 6.76) or without (46%, 6.77) metastatic disease, from healthy participants (40%, 6.80). Breath methane excretors had higher fecal pH than nonexcretors (7.05 versus 6.57, P < 0.001) and less abdominal discomfort (30% versus 54%, P = 0.016). Among patients with resected right-sided cancer (n = 15), there were less breath methane excretors (20%) than among those with resected left-sided cancer (51%, n = 81, P = 0.029) as well as lower fecal pH than among those with resected left-sided cancer (6.27 versus 6.86, P = 0.002) and among healthy subjects (6.80, P = 0.010). Conclusions Patients with resected colorectal cancer were as frequently methane producers as healthy subjects with intact colon, and there was no difference in their fecal pH. Low methanogenesis was found in patients with abdominal discomfort and is a possible characteristic, along with low fecal pH, to right-sided colorectal cancer.Keywords
This publication has 31 references indexed in Scilit:
- The Discussion Goes on: What Is the Role ofEuryarchaeotain Humans?Archaea, 2010
- Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancerCritical Reviews in Microbiology, 2010
- Assessment of metabolic diversity within the intestinal microbiota from healthy humans using combined molecular and cultural approachesFEMS Microbiology Ecology, 2008
- Incidence of Predominant Methanogenic Flora in Irritable Bowel Syndrome Patients and Apparently Healthy Controls from North IndiaDigestive Diseases and Sciences, 2008
- Role of Intestinal Microbiota in Transformation of Bismuth and Other Metals and Metalloids into Volatile Methyl and Hydride Derivatives in Humans and MiceApplied and Environmental Microbiology, 2008
- Methanogenic archaea in adult human faecal samples are inversely related to butyrate concentrationMicrobial Ecology in Health and Disease, 2006
- Breath Methane and Colorectal CancerScandinavian Journal of Gastroenterology, 1992
- Determinants and consequences of colonic luminal pH: Implications for colon cancerNutrition and Cancer, 1990
- Fibre, fermentation, flora, and flatus.Gut, 1989
- Breath methane and large bowel cancer risk in contrasting African populations.Gut, 1988